July 24, 2016 9:47 AM ET

Life Sciences Tools and Services

Company Overview of Mayne Pharma (USA), Inc.

Company Overview

Mayne Pharma (USA), Inc. offers pharmaceutical products and services. The company focuses on two business segments including contract pharmaceutical services and development and manufacturing of branded and generic pharmaceutical products. Additionally, it provides pharmaceutical formulation development; first-time-in-man formulations; clinical trial material manufacturing for phase I, II, and III trials; and analytical method development and validation services. It was formerly known as Faulding Pharmaceuticals Co. and changed its name to Mayne Pharma (USA), Inc. in December 2003. The company was founded in 1995 and is based in Paramus, New Jersey. Mayne Pharma (USA), Inc. operates as a sub...

650 From Road

Mack Cali Centre II

Second Floor

Paramus, NJ 07652

United States

Founded in 1995

Phone:

201-225-5500

Fax:

201-225-5515

Key Executives for Mayne Pharma (USA), Inc.

President
Age: 43
Chief Financial Officer
Age: 59
Vice President of Operations
Chief Compliance Officer and Vice President
Vice President of Business Development
Compensation as of Fiscal Year 2016.

Mayne Pharma (USA), Inc. Key Developments

Mayne Pharma Names Q. Dwight Lewis as Vice President of Quality for U.S. Operations

Mayne Pharma has appointed Q. Dwight Lewis as vice president of quality for its operations in the United States. Lewis is responsible for managing all quality-related functions to ensure that Mayne Pharma’s U.S. pharmaceutical operations – which range from laboratories to manufacturing lines – continue to comply with global regulatory agency and industry standards. Before joining Mayne Pharma, Lewis was senior director of quality for Teva Pharmaceuticals, where he managed quality assurance and control functions for solid dose manufacturing. Prior to that, he served as vice president of quality for Irix Pharmaceuticals, and as director of quality operations for DSM Pharmaceuticals. Lewis brings to his new role expertise in new chemical entity (NCE) development, active pharmaceutical ingredient (API) and solid dose form manufacturing, generic product development, and contract services.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Mayne Pharma (USA), Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.